How does HTLV-I persist despite a strong cell-mediated immune response?

被引：46

作者：

Asquith, Becca ^{[1
]}

Bangharn, Charles R. M. ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Wright Fleming Inst, London W2 1PG, England

来源：

TRENDS IN IMMUNOLOGY | 2008年 / 29卷 / 01期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1016/j.it.2007.09.006

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Human T-lymphotropic virus type 1 (HTLV-1) is a pathogenic retrovirus that infects human CD4(+) T lymphocytes. Despite its presence in T cells, HTLV-1 causes little overt immunosuppression. This host-virus relationship has therefore been exploited as an excellent model system for studying the dynamic interaction between a persistent retrovirus and the normal human immune system. We use a combination of mathematical and experimental techniques to identify key factors on both sides of the in vivo host-virus interaction that significantly determine HTLV-1 proviral load and disease risk. We develop a model to describe how these factors interact to enable viral persistence.

引用

收藏

页码：4 / 11

页数：8

相关论文

共 61 条

[11] Persistent oligoclonal expansion of human T-cell leukemia virus type 1 infected circulating cells in patients with Tropical spastic paraparesis HTLV-1 associated myelopathy [J].

Cavrois, M ;

Leclercq, I ;

Gout, O ;

Gessain, A ;

Wain-Hobson, S ;

Wattel, E .

ONCOGENE, 1998, 17 (01) :77-82

[12] HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes [J].

Collins, KL ;

Chen, BK ;

Kalams, SA ;

Walker, BD ;

Baltimore, D .

NATURE, 1998, 391 (6665) :397-401

[13] High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis [J].

Daenke, S ;

Kermode, AG ;

Hall, SE ;

Taylor, G ;

Weber, J ;

Nightingale, S ;

Bangham, CRM .

VIROLOGY, 1996, 217 (01) :139-146

[14] HIGH HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-1 (HTLV-1) SPECIFIC PRECURSOR CYTOTOXIC T-LYMPHOCYTE FREQUENCIES IN PATIENTS WITH HTLV-1 ASSOCIATED NEUROLOGICAL DISEASE [J].

ELOVAARA, I ;

KOENIG, S ;

BREWAH, AY ;

WOODS, RM ;

LEHKY, T ;

JACOBSON, S .

JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) :1567-1573

[15]

Etoh K, 1997, CANCER RES, V57, P4862

[16] Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost [J].

Fernandez, CS ;

Stratov, I ;

De Rose, R ;

Walsh, K ;

Dale, CJ ;

Smith, MZ ;

Agy, MB ;

Hu, SL ;

Krebs, K ;

Watkins, DI ;

O'Connor, DH ;

Davenport, MP ;

Kent, SJ .

JOURNAL OF VIROLOGY, 2005, 79 (09) :5721-5731

[17] HUMAN T-CELL LEUKEMIA-VIRUS TYPE-1 (HTLV-1) TAX IS EXPRESSED AT THE SAME LEVEL IN INFECTED-CELLS OF HTLV-1-ASSOCIATED MYELOPATHY OR TROPICAL SPASTIC PARAPARESIS PATIENTS AS IN ASYMPTOMATIC CARRIERS BUT AT A LOWER LEVEL IN ADULT T-CELL LEUKEMIA-CELLS [J].

FURUKAWA, Y ;

OSAME, M ;

KUBOTA, R ;

TARA, M ;

YOSHIDA, M .

BLOOD, 1995, 85 (07) :1865-1870

[18] Cellular transformation by the HTLV-I tax protein, a jack-of-all-trades [J].

Gatza, ML ;

Watt, JC ;

Marriott, SJ .

ONCOGENE, 2003, 22 (33) :5141-5149

[19] Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: Peptide-induced T-cell immunity [J].

Hanabuchi, S ;

Ohashi, T ;

Koya, Y ;

Kato, H ;

Hasegawa, A ;

Takemura, F ;

Masuda, T ;

Kannagi, M .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (23) :1775-1783

[20] Abundant Tax protein expression in CD4+T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes [J].

Hanon, E ;

Hall, S ;

Taylor, GP ;

Saito, M ;

Davis, R ;

Tanaka, Y ;

Usuku, K ;

Osame, M ;

Weber, JN ;

Bangham, CRM .

BLOOD, 2000, 95 (04) :1386-1392

← 1 2 3 4 5 6 7 →